Osborne Clarke advised mental health start-up Likeminded on the deal. Germany-based occupational mental health providers Likeminded and nilo.health are joining forces with a vision to become...
Likeminded’s Merger With nilo.health
PL BioScience GmbH’s €7.8 Million Series A Financing
Osborne Clarke advised PL BioScience on the financing round. PL BioScience GmbH completed a EUR 7.8 million Series A financing. The Aachen-based biotechnology company conducts research...
Tenzing’s Acquisition of INCREASE YOUR SKILLS GmbH (IYS)
Osborne Clarke has advised European tech investor Tenzing on the deal. European tech investor Tenzing completed the acquisition of INCREASE YOUR SKILLS GmbH (IYS), a fast-growing cybersecurity...
NaturalX Health Ventures (Schwabe Group)’s Investment in Mybacs
Osborne Clarke advises naturalX Health Ventures on the funding round. naturalX Health Ventures, the venture capital arm of Schwabe Group, completed its investment in a Series A...
Thinksurance’s €22 Million Financing Round
Osborne Clarke advised Segenia Capital on the investment. Thinksurance has completed a financing round with a total volume of €22 million. The financing round was led...
1KOMMA5°’s €215 Million Series B Financing Round
Osborne Clarke and Gunderson Dettmer advised G2 Venture Partners on its investment. 1KOMMA5° has raised €215 million in its Series B financing round. As a result,...
Akquinet’s Acquisition of Enghofer Koch Consulting
Osborne Clarke advised akquinet GmbH on the deal. akquinet GmbH announced the acquisition of Enghofer Koch Consulting GmbH. The takeover was successfully completed on 27 April. The akquinet...
A & O Fischer’s Acquisition of letterei.de Postdienste GmbH
Osborne Clarke advised A & O Fischer GmbH & Co. KG. A & O Fischer GmbH & Co. KG acquired letterei.de Postdienste GmbH, one of the...
Empion’s EUR 2.4 Million Pre-Seed Funding
Osborne Clarke has advised VR Ventures on the deal. Poellath advised Kienbaum. The Berlin-based HR tech startup has raised EUR 2.4 million in pre-seed funding led...
Sylphar NV and Karo Pharma AB’s Purchase of Satin Naturel
Osborne Clarke advised Sylphar NV and Karo Pharma AB on the deal. Sylphar NV and Karo Pharma AB purchased the Satin Naturel business from Del Decus...
Keen Venture Partners’ EUR 25 Million Investment in Lendis
Osborne Clarke advised Keen Venture Partners on the deal. Previously, DN Capital, HV Capital and Picus Capital had already invested a sum of millions in the...
VAMED Gesundheit’s Acquisition of Gesundheitszentrum Chiemgau
IN BRIEF: Osborne Clarke, advised on the matter. Osborne Clarke advised VAMED Gesundheit with a team including Fabian Christoph (Picture – Corporate M&A), Jens Schefzig (Commercial...